Browsing by Author "Restrepo Erazo, Katherine"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients — Real World Study(Dove Medical Press Ltd, 2024) Balcázar Valencia, Carlos Mario; García Ramos, Andrés Felipe; Osorio Toro, Luis Miguel; Ordoñez Guzmán, Yessica Alejandra; Buitrago Gómez, Nathalia; Cabarcas López, William Fernando; Vizcaino Guerrero, Carlos Javier; Daza Arana, Jorge Enrique; Ramírez Rincón, Alex; Restrepo Erazo, KatherinePurpose: Diabetes is a public health problem that requires strategies to impact glycemic control and reduce the risk of long-term medical complications. Pharmacological management is a necessary treatment for this disease. Therefore, semaglutide is an essential tool to achieve the treatment targets. The present study aimed to evaluate the semaglutide effects on a cohort with type 2 diabetes mellitus (T2DM) in Colombia. Materials and Methods: The cohort included 49 patients with T2DM that have been treated in a specialized care center. Their glycemic outcomes, weight, renal function, and adverse events were evaluated through a 3-, 6-and 12-month follow-up. Results: Significant differences were observed in the outcome evaluation: reduction of glycated hemoglobin levels (MD −2.74 CI −1.95 to −3.52 in 6 months), fasting plasma glucose levels, body weight (MD −7.11 CI −5.97 to −8.24), and the albumin-to-creatinine ratio. The results were maintained throughout the treatment period. The adverse event rate was 16.3%, predominating gastrointestinal events. Conclusion: This real-world evidence shows the efficacy of semaglutide in achieving treatment goals in patients with T2DM.